vimarsana.com


RIO DE JANEIRO, BRAZIL - Cuba's Finlay Vaccine Institute (IFV) reported Thursday the combination of two doses of its candidate vaccine Soberana 02 with a booster dose of Soberana Plus had shown 91.2% efficacy against SARS-CoV-2, which causes Covid-19.
Soberana 02 and Soberana Plus - developed by the IFV - are two of the five vaccine projects against the coronavirus being investigated by Cuban scientific institutions.
Preliminary analyses of the third and last phase of clinical trials of . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here

Related Keywords

Cuba ,Soberana ,Estado De Pernambuco ,Brazil ,Cuban , ,Cuba Finlay Vaccine Institute ,Finlay Vaccine Institute ,Soberana Plus ,Premium Membership ,கியூபா ,சோபேரான ,எஸ்டாடோ டி பரர்ந்யாஂப்யூகொ ,பிரேசில் ,கியூபன் ,கியூபா ஃபின்லே தடுப்பூசி நிறுவனம் ,ஃபின்லே தடுப்பூசி நிறுவனம் ,சோபேரான ப்லஸ் ,ப்ரீமியம் உறுப்பினர் ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.